Methods

Chromatographic System
A Shimadzu LC-2010A liquid chromatograph equipped with a SPD-10AVP ultraviolet absorption detector, a class-VP work station, and a Diamonsil ODS C 18 column (5 μm, 150 × 4.6 mm) maintained at 25°C was used for the analysis. The mobile phase consisted of acetonitrile-0.1% (v/v) in aqueous phosphoric acid (H 3 PO 4 ; Merck pro analysis, 85%) (30:70, v/v PH: 3.8 ± 0.2). The solvent flow rate was 1.0 mL/min, and the detection wavelength was 270 nm. The data were acquired and processed with a Class-VP Ver. 6.0 chromatography data system.
HPLC Determination
Stock solutions
The standard stock solutions were prepared by dissolving 6.0 mg CHE and DHCHE in 10 mL methanol to furnish a nominal concentration of 0.6 mg/mL. The IS stock solution was prepared by dissolving 6.0 mg berberine in 10 mL methanol to furnish a nominal concentration of 0.6 mg/mL. All stock solutions were stored at 4 °C but equilibrated to room temperature before use. 
Preparation of calibration plot and quality-control samples
Sample preparation
Plasma sample (100 μL) was mixed with IS (10.0 μg/mL, 100 μL) and methanol (100 μL) on a vortex-mixer for 1min, then the mixed sample was extracted with 2 mL chloroform by mechanical shaking for 3 min.
The extraction was centrifuged at 10'000 g for 10 min, and then the supernatant was transferred to a clean test tube and evaporated to dryness in a water bath at 40°C under a stream of nitrogen. The residue was reconstituted with 100 μL mobile phase. After centrifugation at 4000 g for 10 min, a 40 μL sample of the supernatant was injected into the HPLC system.
Bioanalytical method validation
The method validation assays were performed according to the guidelines for chemicals in non-clinical pharmacokinetic studies [17] , recommended by Ministry of Health, PR China, which included selectivity, linearity, limit of detection (LOD), limit of quantification (LOQ), accuracy, precision, stability, and recovery.
To assess the selectivity of the present method, drug-free plasma samples from six different rats of six batches were extracted and analyzed to assess the potential endogenous interferences. Any apparent response at the retention times of CHE, DHCHE, and IS was compared to the response at the LOQ and the response at the working concentrations for CHE, DHCHE, and IS, respectively. This determines whether there are any interfering peaks at the retention times of CHE, DHCHE, and IS.
To evaluate linearity, spiked plasma standard solutions at seven concentrations in the range 0.01-20.0 μg/mL were prepared in triplicate and analyzed separately three times. The LODs and the LOQs of CHE and DHCHE were determined using a signal-to-noise ratio (S/N) of each peak more than 3 and 10, respectively. The calibration curves were constructed using weighted (1/x 2 ) linear least-squares regression analysis of the observed CHE and DHCHE to IS peak-area ratios against concentration. Unknown sample concentrations were calculated from the linear regression equation for the calibration plot of peak area ratio against concentration.
QC samples at three levels of CHE (0.1, 5.0, and 15.0 μg/mL) and DHCHE (0.05, 0.5, and 5.0μg/mL) were assayed to check the accuracy and intra and inter-day precision of the method. For accuracy and intra-day precision, QC samples (six replicates at each level) were detected and calculated using a calibration curve prepared on the same day. For inter-day precision, QC samples were analyzed over four different days (six replicates at each level per day). Accuracy was expressed as the percentage of the mean calculated concentrations to the nominal concentrations, and precision was evaluated as relative standard deviation (RSD).
Stability experiments were carried out in plasma tissues under different conditions. The stability of CHE and DHCHE were evaluated at low (0.1 μg/mL), medium (5.0 μg/mL), and high (15.0 μg/mL) concentrations in triplicate. All stability results were evaluated by measuring the area response (CHE/IS or DHCHE/IS) of stability samples against the initial concentration as determined for freshly prepared samples. The samples were considered stable when the calculated concentrations in QC samples were within 85-115% of the nominal concentrations. For the short-term temperature stability, samples were kept at room temperature (25°C) for 4 h before sample preparation. The freeze-thaw stability of CHE and DHCHE were determined over three freeze-thaw cycles. In each cycle, the frozen samples were thawed at room temperature for 1 h and refrozen for 24 h. The long-term stability was evaluated after keeping the samples frozen at -20°C for 30 d. The processed samples were stored in the refrigerator at 4°C. Duplicates at each level QC samples were analyzed over 2 d.
The recovery of the liquid-liquid extraction was evaluated at the three QC levels of CHE and DHCHE for 10.0 μg/mL IS. It was determined by comparing the mean peak areas (n=6 at each concentration) obtained from plasma samples spiked before extraction with those from plasma samples spiked after extraction.
Results
Selectivity of the proposed method was assessed by comparing chromatograms of blank plasma with CHE and IS-spiked plasma at the LOQ levels. No interference peak (S/N≥3) in blank plasma at the or near the retention time of CHE, DHCHE, and IS was observed just as shown in Fig. 4 ; it indicated that the extraction procedure was capable of obtaining highly purified samples which in turn ensured a high selectivity of the HPLC method.
The LOD and LOQ of CHE or DHCHE in plasma by HPLC were both found to be 1.0 ng/mL and 4.0 ng/mL, respectively. Concentrations below the LOQ were detected with unacceptable accuracy and precision. The calibration curve was assessed based on a plot of the ratio of peak areas for CHE/IS and DHCHE/IS. A representative regression equation for the calibration plot of CHE was Y=0.0753X+0.0621 over the range 0.02-20 μg/ml, with a correlation coefficient of 0.998. For DHCHE, the calibration plot was Y=0.0682X+0.0425 over the range 0.01-10ug/mL, and the correlation coefficient was 0,994
The intra and inter-day precision were assessed by analyzing quality control samples at three QC concentrations in six duplicates. Tables 1   and 2 show the intra and inter-day precision and accuracy results of CHE and DHCHE, respectively. The accuracy of CHE was in range 94.0-99.7% (intra-day) and 92.0-100.9% (inter-day) with the precision (RSD) of 1.11-8.51% (intra-day) and 0.93-9.78% (inter-day) in plasma, while the accuracy of DHCHE was in range 94.0-97.8% (intra-day) and 96.0-102.2% (inter-day) with the precision (RSD) of 1.08-4.26% (intra-day) and 1.70-8.33% (inter-day). The values obtained were lower than the limits required for biological sample analysis, which demonstrates that both precision and accuracy meet the requirements of the current Chinese Pharmacopoeia (2010) [1] .
The stability tests of CHE and DHCHE were made to cover the real conditions that samples may experience. The results are summarized in Table 3 . The short-term temperature stability results showed that the corresponding accuracies of CHE and DHCHE were 96.0%, 98.6%, 96.2% and 93.0%, 97.5%, 99.0% for samples spiked with 0.1 μg/mL, 5.0 μg/mL, and 15.0 μg/mL, respectively, which demonstrated that CHE in plasma was stable in room temperature (25°C) for at least 4 h. After three
